Marketing Psychiatric Drugs to Jailers and Judges

Drug companies that market long-lasting psychiatric drugs have found new clientele in courtrooms and prisons, as a means to treat mental health issues for those that have been incarcerated. Although the practice of targeting judges and prison officials is controversial, several jails have attested that having free samples of the drugs has led to positive outcomes such as reducing barriers for inmates to receive medication and decreasing the likelihood of reoffending.

Related Stories